ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink tough lung tumors
Disease control Recruiting nowThis study tests two experimental drugs, ubamatamab and REGN7075, in 300 people with advanced non-small cell lung cancer that has spread. The goal is to see if the combination can shrink tumors and control the disease. A third drug, sarilumab, may be used to manage immune-related…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug cocktail aims to shrink Hard-to-Treat lung tumors
Disease control Recruiting nowThis study tests a new medicine called PF-08634404 combined with other cancer drugs in people with advanced non-small cell lung cancer that has spread and cannot be removed by surgery. The goal is to see if the combination is safe and can shrink tumors. About 162 adults will rece…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 18, 2026 12:03 UTC